Serle Janet, Cantor Louis, Gross Ron, Katz Jay, Mundorf Thomas, Noecker Robert, Severin Todd, Simmons Steve, Walt John, Casciano Julian, Evans Stacy, Doyle John
Mount Sinai School of Medicine, New York City, USA.
Manag Care Interface. 2002 Jul;15(7):37-48.
The objective of this study was to develop a "best-practice" treatment algorithm for the management of primary open-angle glaucoma in patients receiving initial medical therapy, to serve as a consideration for future ophthalmology practice. For comparison, a baseline, "common-practice" treatment algorithm was also created that reflects current ophthalmology practice patterns. Survey instruments were developed based on a comprehensive review of relevant literature, along with input from a general ophthalmologist. A panel of eight ophthalmologists subspecialized in glaucoma management was surveyed. Consensus was achieved using a modified Delphi technique. A comparison of common- and best-practice treatment algorithms suggests that in contrast with expert opinion, nonselective beta blockers are currently used more often, and alpha-2 agonists less often, as first-line therapy for the treatment of primary open-angle glaucoma.
本研究的目的是为接受初始药物治疗的原发性开角型青光眼患者制定一种“最佳实践”治疗方案,以供未来眼科实践参考。作为对比,还创建了一种反映当前眼科实践模式的基线“常规实践”治疗方案。在全面回顾相关文献以及综合一名普通眼科医生的意见后,开发了调查问卷。对八名青光眼治疗亚专科的眼科医生组成的小组进行了调查。采用改良的德尔菲技术达成共识。常规实践与最佳实践治疗方案的对比表明,与专家意见相反,目前非选择性β受体阻滞剂作为原发性开角型青光眼的一线治疗药物使用更为频繁,而α2激动剂的使用则较少。